Year |
Citation |
Score |
2015 |
Hufnagel RB, Arno G, Hein ND, Hersheson J, Prasad M, Anderson Y, Krueger LA, Gregory LC, Stoetzel C, Jaworek TJ, Hull S, Li A, Plagnol V, Willen CM, Morgan TM, et al. Neuropathy target esterase impairments cause Oliver-McFarlane and Laurence-Moon syndromes. Journal of Medical Genetics. 52: 85-94. PMID 25480986 DOI: 10.1136/Jmedgenet-2014-102856 |
0.51 |
|
2015 |
Richardson RJ, Mark Worden R, Wijeyesakere SJ, Hein ND, Fink JK, Makhaeva GF. Neuropathy Target Esterase as a Biomarker and Biosensor of Delayed Neuropathic Agents Handbook of Toxicology of Chemical Warfare Agents: Second Edition. 935-952. DOI: 10.1016/B978-0-12-800159-2.00063-4 |
0.623 |
|
2014 |
Makhaeva GF, Rudakova EV, Hein ND, Serebryakova OG, Kovaleva NV, Boltneva NP, Fink JK, Richardson RJ. Further studies toward a mouse model for biochemical assessment of neuropathic potential of organophosphorus compounds. Journal of Applied Toxicology : Jat. 34: 1426-35. PMID 24395470 DOI: 10.1002/Jat.2977 |
0.56 |
|
2013 |
Landouré G, Zhu PP, Lourenço CM, Johnson JO, Toro C, Bricceno KV, Rinaldi C, Meilleur KG, Sangaré M, Diallo O, Pierson TM, Ishiura H, Tsuji S, Hein N, Fink JK, et al. Hereditary spastic paraplegia type 43 (SPG43) is caused by mutation in C19orf12. Human Mutation. 34: 1357-60. PMID 23857908 DOI: 10.1002/Humu.22378 |
0.367 |
|
2013 |
Richardson RJ, Hein ND, Wijeyesakere SJ, Fink JK, Makhaeva GF. Neuropathy target esterase (NTE): overview and future. Chemico-Biological Interactions. 203: 238-44. PMID 23220002 DOI: 10.1016/J.Cbi.2012.10.024 |
0.624 |
|
2010 |
Hein ND, Rainier SR, Richardson RJ, Fink JK. Motor neuron disease due to neuropathy target esterase mutation: enzyme analysis of fibroblasts from human subjects yields insights into pathogenesis. Toxicology Letters. 199: 1-5. PMID 20603202 DOI: 10.1016/J.Toxlet.2010.06.020 |
0.565 |
|
2010 |
Hein ND, Stuckey JA, Rainier SR, Fink JK, Richardson RJ. Constructs of human neuropathy target esterase catalytic domain containing mutations related to motor neuron disease have altered enzymatic properties. Toxicology Letters. 196: 67-73. PMID 20382209 DOI: 10.1016/J.Toxlet.2010.03.1120 |
0.597 |
|
2010 |
Makhaeva GF, Aksinenko AY, Sokolov VB, Baskin II, Palyulin VA, Zefirov NS, Hein ND, Kampf JW, Wijeyesakere SJ, Richardson RJ. Kinetics and mechanism of inhibition of serine esterases by fluorinated aminophosphonates. Chemico-Biological Interactions. 187: 177-84. PMID 20035729 DOI: 10.1016/J.Cbi.2009.12.018 |
0.587 |
|
Show low-probability matches. |